Deutsche Bank
CGEM icon

Deutsche Bank’s Cullinan Oncology CGEM Stock Holding History

Deutsche Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.8M Sell
377,837
-5,003
-1% -$95.8K ﹤0.01% 1177
2026
Q2 		$6.97M Buy
382,840
+14,934
+4% +$222K ﹤0.01% 1198
2026
Q1 		$5.23M Sell
367,906
-218,730
-37% -$2.81M ﹤0.01% 1276
2025
Q4 		$6.07M Buy
586,636
+14,898
+3% +$134K ﹤0.01% 1229
2025
Q3 		$3.39M Buy
571,738
+4,957
+0.9% +$36.3K ﹤0.01% 1481
2025
Q2 		$4.27M Sell
566,781
-8,750
-2% -$70.3K ﹤0.01% 1309
2025
Q1 		$4.36M Sell
575,531
-4,605
-0.8% -$44.2K ﹤0.01% 1314
2024
Q4 		$7.07M Buy
580,136
+19,263
+3% +$277K ﹤0.01% 1165
2024
Q3 		$9.39M Buy
560,873
+5,806
+1% +$103K ﹤0.01% 1031
2024
Q2 		$9.7M Buy
555,067
+5,791
+1% +$123K ﹤0.01% 1018
2024
Q1 		$9.36M Buy
549,276
+3,692
+0.7% +$57K ﹤0.01% 1047
2023
Q4 		$5.56M Buy
545,584
+540,967
+11,717% +$4.79M ﹤0.01% 1208
2023
Q3 		$41.8K Sell
4,617
-3,676
-44% -$38.3K ﹤0.01% 3438
2023
Q2 		$89.2K Sell
8,293
-7,670
-48% -$81.5K ﹤0.01% 3321
2023
Q1 		$163K Buy
15,963
+3,654
+30% +$40.3K ﹤0.01% 3102
2022
Q4 		$130K Buy
12,309
+204
+2% +$2.48K ﹤0.01% 3203
2022
Q3 		$155K Sell
12,105
-1,993
-14% -$26.9K ﹤0.01% 3087
2022
Q2 		$181K Sell
14,098
-264
-2% -$2.99K ﹤0.01% 3232
2022
Q1 		$150K Sell
14,362
-1,662
-10% -$22.5K ﹤0.01% 3413
2021
Q4 		$247K Buy
16,024
+822
+5% +$16.4K ﹤0.01% 3273
2021
Q3 		$343K Buy
15,202
+6,882
+83% +$184K ﹤0.01% 3268
2021
Q2 		$214K Sell
8,320
-262
-3% -$8.06K ﹤0.01% 3747
2021
Q1 		$358K Buy
+8,582
New +$348K ﹤0.01% 3312

Other funds holding CGEM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Ellsworth Advisors
Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Deutsche Bank's CGEM Position: Q3 2026 in Review

Deutsche Bank reduced its Cullinan Oncology (CGEM) stake by 1.3% in Q3 2026, selling an estimated $95.8K and leaving 377,837 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Deutsche Bank first reported a position in CGEM in Q1 2021 and has held it in 23 quarters since. The position peaked at $9.7M in Q2 2024. 58 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Deutsche Bank held 377,837 shares of Cullinan Oncology worth $5.8M as of Q3 2026.
  • Deutsche Bank sold 5,003 Cullinan Oncology shares in Q3 2026, an estimated $95.8K.
  • Cullinan Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1177 holding.
  • Deutsche Bank first reported a position in Cullinan Oncology in Q1 2021 and has held it in 23 quarters since.
  • Deutsche Bank's Cullinan Oncology position peaked at $9.7M in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.